LONDON, 7 October 2007 - Following the announcement, as required under Jordanian Securities Rules, by Arab Pharmaceutical Manufacturing Co. Ltd. (”APMC”) (ASE: APMC), a Jordanian pharmaceutical manufacturer listed on the Amman Stock Exchange, Hikma Pharmaceuticals PLC (”Hikma”) (LSE: HIK) (DIFX: HIK), announces that it has made a conditional offer (”the Offer”) to acquire APMC for JD 116.0 million, or approximately $163.6 million. The Offer is conditional inter alia upon the successful completion of due diligence, APMC shareholder approval and regulatory approval.
